Type 1 diabetes mellitus (T1DM) typically involves autoimmune destruction of pancreatic β-cells, resulting in insulin deficiency and rapid progression to absolute insulin dependency [1], and is primarily distinguished from type 2 diabetes mellitus (T2DM), manifesting insulin resistance, relative insulin deficiency, and the absence of islet autoantibodies. This evidence concerns the gene INS and type 1 diabetes mellitus.